Day: March 28, 2025

Vicon’s new markerless system enabling Dreamscape Immersive’s latest VR experience

Written by Customer Service on March 28, 2025. Posted in Public Companies.

28 March 2025 Oxford Metrics plc (“Oxford Metrics” or the “Group”) Vicon’s new markerless system enabling Dreamscape Immersive’s latest VR experience New location-based VR technology to launch at Dreamscape’s Geneva flagship store in partnership with Swiss research partner, Artanim Oxford Metrics plc (LSE: OMG), the smart sensing and software company servicing life sciences, entertainment, engineering and smart manufacturing markets, announces that Vicon, its motion capture division, will be powering Dreamscape’s latest Location Based Virtual Reality (“LBVR”) experience, with its recently launched Vicon Markerless system. For Dreamscape, markerless motion capture can now provide a more true-to-life adventure than any other immersive VR experience by allowing more free-flowing movement and exploration without the need for markers...

Fly Play hf.: Play Europe Receives Air Operator Certificate in Malta

Written by Customer Service on March 28, 2025. Posted in Public Companies.

Play Europe, a subsidiary of Fly Play hf., has been granted an Air Operator Certificate (AOC) from the Civil Aviation Directorate in Malta. The certificate was presented at a formal ceremony held in Malta this morning. Play Europe was established as part of a restructuring process announced by Fly Play hf. in October of last year. At that time, the company announced that it would carry out projects in Europe for other airlines through its subsidiary, Play Europe, based in Malta. Fly Play hf. currently operates a fleet of ten aircraft. Play has already reached an agreement with an airline operator in Eastern Europe, which includes the lease of three aircraft under the new Maltese Air Operator Certificate (AOC). These aircraft will operate exclusively outside of Iceland and not under the Play brand. In other words, they will not fly to...

Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American Association for Cancer Research Meeting

Written by Customer Service on March 28, 2025. Posted in Public Companies.

REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 American Association for Cancer Research Meeting (2025 AACR), scheduled to take place from April 25th to April 30th in Chicago. Presentation details are below: Abstract Title: Final analysis of the randomized Phase 2 cohort of CM24 with nivolumab and chemotherapy in pancreatic cancer & potential serum biomarkers Session Title: Liquid Biopsy: Circulating Nucleic...

Aya Gold & Silver Reports Q4 and Full Year 2024 Results; Announces 2025 Production and Cost Guidance

Written by Customer Service on March 28, 2025. Posted in Earnings Releases And Operating Results.

MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced financial and operational results for the fourth quarter and full year ended December 31, 2024. All amounts are in US dollars, unless otherwise stated. Full Year 2024 HighlightsSilver produced totaled 1,646,265 ounces (“oz”) in 2024 compared to 1,970,646 oz in 2023, is in line with revised guidance of 1.6 to 1.8 million (“M”) silver (“Ag”) oz. Ore processed increased 27% to 358,919 tonnes (“t”) in 2024 compared with 281,634t in 2023. Revenues reported from silver sales generated $39.1M (decreasing 9% over 2023), at an average realized silver price of $26.04/oz. Adjusted cash cost per silver ounce sold(i)totaled $19.62/oz in 2024, compared with $12.50/oz in 2023. The increase in year-over-year...

Bio-Path Holdings Reports Full Year 2024 Financial Results

Written by Customer Service on March 28, 2025. Posted in Earnings Releases And Operating Results.

Reports Continued Progress Across Both Obesity and Oncology Franchises HOUSTON, March 28, 2025 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (OTCQB:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced its financial results for the year ended December 31, 2024 and provided an update on recent corporate developments. “We are merely touching the tip of the iceberg in terms of realizing the potential of our DNAbilize® platform to change the treatment paradigm in both obesity and oncology,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings. “Throughout the last year, we built on the body of scientific evidence in support of our powerful platform technologies’ therapeutic...

CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates

Written by Customer Service on March 28, 2025. Posted in Earnings Releases And Operating Results.

– Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) – – Initiated CORE-008 Clinical Trial of Cretostimogene Monotherapy in High-Risk BCG-Naïve (Cohort A) and BCG-Exposed (Cohort B) NMIBC – – Late-Breaking Clinical and First Translational Data from BOND-003 Cohort C Presented at the 40th Annual European Association of Urology Congress – – Completed Oversubscribed $238 Million Follow-on Public Equity Offering that Extends Expected Runway into the First Half of 2028 – IRVINE, Calif., March 28, 2025 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

60 Degrees Pharmaceuticals Announces 2024 Annual Results

Written by Customer Service on March 28, 2025. Posted in Earnings Releases And Operating Results.

FY 2024 net product revenues increased 140% to $607.6 thousand. FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 thousand.WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024. Financial Highlights for the Fiscal Year Ended December 31, 2024:Net product revenues increased 140% from $253.6 thousand for fiscal year 2023 to $607.6 thousand for fiscal year 2024; the Company credits growth from domestic commercial sales of ARAKODA®. The Company achieved a gross profit of approximately $222.8 thousand in fiscal year 2024, compared to an approximate gross loss of $221...

Amplify ETFs Declares March Income Distributions for its Income ETFs

Written by Customer Service on March 28, 2025. Posted in Dividend Reports And Estimates.

CHICAGO, March 28, 2025 (GLOBE NEWSWIRE) — Amplify ETFs announces March income distributions for its income ETFs.ETF Name Ticker Amount per Share Ex-Date Record Date Payable DateAmplify Samsung SOFR ETF SOFR $0.36162 3/28/25 3/28/25 3/31/25Amplify Bloomberg U.S. Treasury 12% Premium Income ETF TLTP $0.23680 3/28/25 3/28/25 3/31/25Amplify CWP Growth & Income ETF QDVO $0.21041 3/28/25 3/28/25 3/31/25Amplify COWS Covered Call ETF HCOW $0.20333 3/28/25 3/28/25 3/31/25Amplify CWP Enhanced Dividend Income ETF DIVO $0.16468 3/28/25 3/28/25 3/31/25Amplify CWP International Enhanced Dividend Income ETF IDVO $0.16155 3/28/25 3/28/25 3/31/25Amplify Natural Resources Dividend Income ETF NDIV $0.12901 3/28/25 3/28/25 3/31/25Amplify High Income ETF YYY $0.12000 3/28/25 3/28/25 3/31/25About Amplify ETFsAmplify...

LYB to discuss first-quarter results Friday, April 25, 2025

Written by Customer Service on March 28, 2025. Posted in Earnings Releases And Operating Results.

HOUSTON and LONDON, March 28, 2025 (GLOBE NEWSWIRE) — LyondellBasell (NYSE: LYB), a leader in the global chemical industry, will announce its first-quarter 2025 financial results before the U.S. market opens Friday, April 25, followed by a webcast and teleconference to discuss the results at 11 a.m. EDT. Teleconference and webcast detailsFriday, April 25, 202511 a.m. EDTHosted by David Kinney, head of investor relationsAccess the webcast 10 to 15 minutes prior to the start of the call at www.lyondellbasell.com/earnings. Toll-free teleconference dial-in numbersParticipant/Guest toll-free: 877-407-8029Participant/Guest toll: 201-689-8029Participant/Guest: CallMe link Presentation slidesPresentation slides will be available at the time of the teleconference and afterward at www.lyondellbasell.com/earnings. Replay informationA...

Ashland to host 2025 Innovation Day for analysts and investors

Written by Customer Service on March 28, 2025. Posted in Public Companies.

WILMINGTON, Del., March 28, 2025 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) is hosting an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility, Thursday, May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland’s scalable technology platforms. Registration is required, with options to attend via live webcast or in person. Participants will join Ashland’s executive and senior technology team for an in-depth review of the latest developments and their expanding commercial opportunities. The presentations will detail how these advancements are poised to impact key markets and drive future growth. Following the presentation, participants will have the opportunity to engage directly with Ashland’s senior leadership in a moderated question and...

Day: March 28, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals